ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

News from the ECOG-ACRIN Cancer Research Group
February 19, 2025
Dr. O'Dwyer and Dr. Schnall
February 19, 2025
Categories
  • From the Co-Chairs

From the Co-Chairs, February 2025

The co-chairs highlight the immense value of Cooperative Group cancer research and the importance of its continued funding
Do you like it?
0 Read more
February 19, 2025
February 19, 2025
Categories
  • Active Clinical Trials

Now Enrolling: EA4232 for Patients With Peripheral T-Cell Lymphoma

This is the first randomized phase 3 study to evaluate autologous stem cell transplantation in patients with this rare and aggressive form of non-Hodgkin lymphoma
Do you like it?
0 Read more
February 19, 2025
Woman on smartphone
February 19, 2025
Categories
  • Special Topics

The Value of Patient-Reported Outcomes in Enhancing the Relevance of Clinical Trials

Patient-reported outcomes research has led to many discoveries that have influenced current research priorities and the way the Group designs its trials
Do you like it?
0 Read more
February 19, 2025
Research definition
February 19, 2025
Categories
  • Trial Results

Top Trial Results of 2024: A Year of Significant Advancements in Cancer Treatment

Seven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG
Do you like it?
0 Read more
February 19, 2025
News in Brief
February 19, 2025
Categories
  • News in Brief

News in Brief, February 2025

Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org

Tags

Acute lymphoblastic leukemia (ALL) Advanced practice providers Advocacy ASCO Breast cancer Cancer care delivery research Cancer control Cancer screening Cancer surveillance Chemotherapy Clinical trials Colorectal cancer Comis Symposium Communication COVID-19 Diversity GI cancer Group Meeting Head and neck cancer Head and neck squamous cell carcinoma Health equity Immunotherapy In memory Kidney cancer Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Myeloma NCI NCI-MATCH NCORP Non-small cell lung cancer Pancreatic cancer Precision medicine Prostate cancer Real-world data Research results Sarcoma Social determinants of health Survivorship Targeted therapy TMIST
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc